BioCentury
ARTICLE | Company News

Ajinomoto, Astellas deal

November 12, 2012 8:00 AM UTC

In its earnings for fiscal 2Q12 ended Sept. 30, Astellas said the companies partnered in October to conduct trials of Starsis nateglinide in combination with inhibitors of dipeptidyl peptidase-4 (DP...